People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Seattle Genetics Inc /Wa | — | Other | Series A | $11.5M | $173.3M | 2009 |
Mark E. Lippman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark E. Lippman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Srinivas Akkaraju | 1 | 10 |
| Franklin M. Berger | 1 | 4 |
| Felix Baker | 1 | 4 |
| John P. McLaughlin | 1 | 2 |
| Thomas C. Reynolds | 1 | 2 |
| Daniel F. Hoth | 1 | 2 |
| Daniel G. Welch | 1 | 2 |
| Todd E. Simpson | 1 | 1 |
| Morris Z. Rosenberg | 1 | 1 |
| David W. Gryska | 1 | 1 |
| Clay B. Siegall | 1 | 1 |
| Eric L. Dobmeier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.